Aktive Positionen von Didier Véron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Leem | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Didier Véron
Ehemalige bekannte Positionen von Didier Véron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IPSEN | Public Communications Contact | 01.01.2013 | 01.12.2018 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Public Communications Contact | 25.08.2010 | 03.02.2014 |
Ausbildung von Didier Véron
| Sciences Po | Undergraduate Degree |
Statistik
International
| Frankreich | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Public Communications Contact | 2 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IPSEN | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
| Leem | |
| Université de Paris XI Paris Sud | Consumer Services |
- Börse
- Insiders
- Didier Véron
- Erfahrung
